Metagenomics of Parkinson Disease Implicates ...

The August 2026 recall showcases five incredible interviews highlighting recent advances in headache medicine. The episode begins with Dr. Patricia Pozo-Rosich discussing the latest advancements in headache medicine, focusing on key research findings from 2025. The episode contin ...  Show more

In part two of this series, Dr. Shuvro Roy talks with Drs. Jiwon Oh and Amit Bar-Or about the latest developments in BTK inhibitors for MS, including safety signals, trial results, and future directions. For more information, please read about the abstract that was presented at t ...  Show more

This week, I am joined by microbiologist Dr. Sarkis Mazmanian, the Luis B. and Nelly Soux Professor at Caltech, to discuss the microbiome's connection to human health—especially the gut-brain axis. Dr. Mazmanian discusses his research evolution from infectious diseases to the mic ...  Show more

Dr. Jason Crowell and Dr. Colin Hoy discuss the concept of prodromal Parkinson disease and the ethical considerations surrounding its diagnosis.  Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209522   

Guest: Jeremy K. Cutsforth-Gregory, M.D. (@JCGneuro)

Host: Darryl S. Chutka, M.D. (@ChutkaMD)

Parkinson’s Disease is one of the more common neurodegenerative diseases, in fact, ...

This month's episode is an encore presentation of an interview with Dr. Guy Caldwell from the University of Alabama. Dr. Caldwell explains how tools from molecular biology make it possibl ...